Natixis Advisors, L.P. Invitae Corp Transaction History

Natixis Advisors, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$14.7 - $28.67 $275,139 - $536,616	-18,717 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$24.31 - $33.6 $66,755 - $92,265	-2,746 Reduced 12.79%	18,717 $532,000
Q2 2021 Aug 12, 2021	SELL	$26.09 - $40.4 $283,415 - $438,865	-10,863 Reduced 33.6%	21,463 $724,000
Q1 2021 May 05, 2021	SELL	$33.06 - $56.93 $31,340 - $53,969	-948 Reduced 2.85%	32,326 $1.24 Million
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $1.3 Million - $1.91 Million	33,274 New	33,274 $1.39 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.